NCT04765553View on ClinicalTrials.gov

A Study to Evaluate Emapalumab in Japanese Healthy Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 14, 2021

Primary Completion Date

June 25, 2021

Study Completion Date

July 25, 2021

Conditions
Rare Diseases
Interventions
DRUG

NI-0501

emapalumab single i.v infusion (1 mg/kg)

DRUG

Saline

Saline single i.v infusion

Trial Locations (1)

Unknown

P-One Clinic, Tokyo

Sponsors
All Listed Sponsors
lead

Swedish Orphan Biovitrum

INDUSTRY